Back to Search Start Over

Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 2

Authors :
Ana, Allende
Konstantinos, Koutsoumanis
Avelino, Alvarez-Ordóñez
Declan, Bolton
Sara, Bover-Cid
Marianne, Chemaly
Robert, Davies
Alessandra, De Cesare
Lieve, Herman
Friederike, Hilbert
Roland, Lindqvist
Maarten, Nauta
Giuseppe, Ru
Marion, Simmons
Panagiotis, Skandamis
Elisabetta, Suffredini
Dan I, Andersson
Vasileios, Bampidis
Johan, Bengtsson-Palme
Damien, Bouchard
Aude, Ferran
Maryline, Kouba
Secundino, López Puente
Marta, López-Alonso
Søren Saxmose, Nielsen
Alena, Pechová
Mariana, Petkova
Sebastien, Girault
Alessandro, Broglia
Beatriz, Guerra
Matteo Lorenzo, Innocenti
Ernesto, Liébana
Gloria, López-Gálvez
Paola, Manini
Pietro, Stella
Luisa, Peixe
Source :
EFSA Journal
Publication Year :
2021

Abstract

The specific concentrations of apramycin, paromomycin, neomycin and spectinomycin in non‐target feed for food‐producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield, were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. However, due to the lack of data on the parameters required to calculate the FARSC for these antimicrobials, it was not possible to conclude the assessment until further experimental data become available. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels in feed that showed to have an effect on growth promotion/increased yield were reported for apramycin and neomycin, whilst for paromomycin and spectinomycin, no suitable data for the assessment were available. It was recommended to carry out studies to generate the data that are required to fill the gaps which prevented the calculation of the FARSC for these four antimicrobials.

Details

ISSN :
18314732
Volume :
19
Issue :
10
Database :
OpenAIRE
Journal :
EFSA journal. European Food Safety Authority
Accession number :
edsair.pmid..........f3f0ad5c7d00b1f683724bcb66f87039